Correlation Between CRISPR Therapeutics and Bio Techne

Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Bio Techne at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Bio Techne into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CRISPR Therapeutics AG and Bio Techne, you can compare the effects of market volatilities on CRISPR Therapeutics and Bio Techne and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Bio Techne. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Bio Techne.

Diversification Opportunities for CRISPR Therapeutics and Bio Techne

-0.24

Correlation Coefficient

CRISPR Therapeutics  Bio Techne

Very good diversification

The 3 months correlation between CRISPR and Bio is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Bio Techne in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Techne and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Bio Techne. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Techne has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Bio Techne go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and Bio Techne

Assuming the 90 days trading horizon CRISPR Therapeutics AG is expected to generate 2.7 times more return on investment than Bio Techne. However, CRISPR Therapeutics is 2.7 times more volatile than Bio Techne. It trades about -0.01 of its potential returns per unit of risk. Bio Techne is currently generating about -0.34 per unit of risk. If you would invest  3,159  in CRISPR Therapeutics AG on December 24, 2024 and sell it today you would lose (219.00) from holding CRISPR Therapeutics AG or give up 6.93% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.31%
Values	Daily Returns

CRISPR Therapeutics AG  vs.  Bio Techne

CRISPR Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days CRISPR Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, CRISPR Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Bio Techne

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bio Techne has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with CRISPR Therapeutics and Bio Techne

The main advantage of trading using opposite CRISPR Therapeutics and Bio Techne positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Bio Techne can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Techne will offset losses from the drop in Bio Techne's long position.

The idea behind CRISPR Therapeutics AG and Bio Techne pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.